Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
NCT04078568Phase 3Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jan 2020
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone in Kawasaki disease (KD), sponsored by Children's Hospital of Fudan University. Started Jan 2020; status: completed.
02
Drugs
prednisolone
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT04078568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04078568.